Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank E Blaney

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 3, 2008
Novel 5-HT(1A/1B/1D) receptors antagonists with potent 5-HT reuptake inhibitory activityHalina T Serafinowska, Frank E Blaney, Peter J Lovell, et al.
Proteins|February 24, 2005
Functional analysis of CYP2D6.31 variant: homology modeling suggests possible disruption of redox partner interaction by Arg440His substitutionDelphine Allorge, Didier Bréant, Jacky Harlow, et al.
Bioorganic & Medicinal Chemistry Letters|November 30, 2006
3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitorsPeter J Lovell, Frank E Blaney, Caroline J Goodacre, et al.
The Journal of Biological Chemistry|December 15, 2005
Crystal structure of human cytochrome P450 2D6Paul Rowland, Frank E Blaney, Martin G Smyth, et al.
Biochemical Society Transactions|March 23, 2012
G-protein-coupled receptor dynamics: dimerization and activation models compared with experimentBruck Taddese, Lisa M Simpson, Ian D Wall, et al.
Journal of Medicinal Chemistry|March 26, 2009
Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonistsDramane I Lainé, Brent McCleland, Sonia Thomas, et al.
Journal of Medicinal Chemistry|September 5, 2003
CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approachTheo A Berkhout, Frank E Blaney, Angela M Bridges, et al.
Journal of Medicinal Chemistry|November 4, 2008
Dihydropyrrole[2,3-d]pyridine derivatives as novel corticotropin-releasing factor-1 antagonists: mapping of the receptor binding pocket by in silico docking studiesRomano Di Fabio, Roberto Arban, Giovanni Bernasconi, et al.
Journal of Medicinal Chemistry|July 28, 2009
Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonistsDramane I Lainé, Zehong Wan, Hongxing Yan, et al.
Journal of Medicinal Chemistry|November 7, 2009
1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonistsFabrizio Micheli, Luca Arista, Giorgio Bonanomi, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|October 3, 2008
Novel 5-HT(1A/1B/1D) receptors antagonists with potent 5-HT reuptake inhibitory activityHalina T Serafinowska, Frank E Blaney, Peter J Lovell, et al.
Proteins|February 24, 2005
Functional analysis of CYP2D6.31 variant: homology modeling suggests possible disruption of redox partner interaction by Arg440His substitutionDelphine Allorge, Didier Bréant, Jacky Harlow, et al.
Bioorganic & Medicinal Chemistry Letters|November 30, 2006
3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitorsPeter J Lovell, Frank E Blaney, Caroline J Goodacre, et al.
The Journal of Biological Chemistry|December 15, 2005
Crystal structure of human cytochrome P450 2D6Paul Rowland, Frank E Blaney, Martin G Smyth, et al.
Biochemical Society Transactions|March 23, 2012
G-protein-coupled receptor dynamics: dimerization and activation models compared with experimentBruck Taddese, Lisa M Simpson, Ian D Wall, et al.
Journal of Medicinal Chemistry|March 26, 2009
Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonistsDramane I Lainé, Brent McCleland, Sonia Thomas, et al.
Journal of Medicinal Chemistry|September 5, 2003
CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approachTheo A Berkhout, Frank E Blaney, Angela M Bridges, et al.
Journal of Medicinal Chemistry|November 4, 2008
Dihydropyrrole[2,3-d]pyridine derivatives as novel corticotropin-releasing factor-1 antagonists: mapping of the receptor binding pocket by in silico docking studiesRomano Di Fabio, Roberto Arban, Giovanni Bernasconi, et al.
Journal of Medicinal Chemistry|July 28, 2009
Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonistsDramane I Lainé, Zehong Wan, Hongxing Yan, et al.
Journal of Medicinal Chemistry|November 7, 2009
1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonistsFabrizio Micheli, Luca Arista, Giorgio Bonanomi, et al.
Pageof 3